Global Hepatitis C Treatment Market Research Report 2018

Published On: Dec 2018

Format: PDF

Publisher: QY Research

Pages: 117

Report ID: 214439



This report studies the global Hepatitis C Treatment market status and forecast, categorizes the global Hepatitis C Treatment market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia).

The major manufacturers covered in this report
AbbieVie Inc.
Bristol-Myers Squibb Company
F. Hoffmann-La Roche AG
Gilead Sciences Inc.
GlaxoSmith Kline Plc.
Janssen Pharmaceuticals Inc.
Merck & Co. Inc.
Schering AG
Vertex Pharmaceuticals

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering
North America
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
HCV Protease Inhibitors
HCV Polymerase Inhibitors
HCV NS5A Inhibitors
Combination Therapy
Interferon and Antiviral
Others
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Hospital
Clinic
Home Care

The study objectives of this report are:
To analyze and study the global Hepatitis C Treatment capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
Focuses on the key Hepatitis C Treatment manufacturers, to study the capacity, production, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Hepatitis C Treatment are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Hepatitis C Treatment Manufacturers
Hepatitis C Treatment Distributors/Traders/Wholesalers
Hepatitis C Treatment Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Hepatitis C Treatment market, by end-use.
Detailed analysis and profiles of additional market players.

Table of Contents

Global Hepatitis C Treatment Market Research Report 2018
1 Hepatitis C Treatment Market Overview
1.1 Product Overview and Scope of Hepatitis C Treatment
1.2 Hepatitis C Treatment Segment by Type (Product Category)
1.2.1 Global Hepatitis C Treatment Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
1.2.2 Global Hepatitis C Treatment Production Market Share by Type (Product Category) in 2017
1.2.3 HCV Protease Inhibitors
1.2.3 HCV Polymerase Inhibitors
1.2.5 HCV NS5A Inhibitors
1.2.6 Combination Therapy
1.2.7 Interferon and Antiviral
Others
1.3 Global Hepatitis C Treatment Segment by Application
1.3.1 Hepatitis C Treatment Consumption (Sales) Comparison by Application (2013-2025)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Home Care
1.4 Global Hepatitis C Treatment Market by Region (2013-2025)
1.4.1 Global Hepatitis C Treatment Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
1.4.2 North America Status and Prospect (2013-2025)
1.4.3 Europe Status and Prospect (2013-2025)
1.4.4 China Status and Prospect (2013-2025)
1.4.5 Japan Status and Prospect (2013-2025)
1.4.6 Southeast Asia Status and Prospect (2013-2025)
1.4.7 India Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Hepatitis C Treatment (2013-2025)
1.5.1 Global Hepatitis C Treatment Revenue Status and Outlook (2013-2025)
1.5.2 Global Hepatitis C Treatment Capacity, Production Status and Outlook (2013-2025)

2 Global Hepatitis C Treatment Market Competition by Manufacturers
2.1 Global Hepatitis C Treatment Capacity, Production and Share by Manufacturers (2013-2018)
2.1.1 Global Hepatitis C Treatment Capacity and Share by Manufacturers (2013-2018)
2.1.2 Global Hepatitis C Treatment Production and Share by Manufacturers (2013-2018)
2.2 Global Hepatitis C Treatment Revenue and Share by Manufacturers (2013-2018)
2.3 Global Hepatitis C Treatment Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Hepatitis C Treatment Manufacturing Base Distribution, Sales Area and Product Type
2.5 Hepatitis C Treatment Market Competitive Situation and Trends
2.5.1 Hepatitis C Treatment Market Concentration Rate
2.5.2 Hepatitis C Treatment Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Hepatitis C Treatment Capacity, Production, Revenue (Value) by Region (2013-2018)
3.1 Global Hepatitis C Treatment Capacity and Market Share by Region (2013-2018)
3.2 Global Hepatitis C Treatment Production and Market Share by Region (2013-2018)
3.3 Global Hepatitis C Treatment Revenue (Value) and Market Share by Region (2013-2018)
3.4 Global Hepatitis C Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.5 North America Hepatitis C Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.6 Europe Hepatitis C Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.7 China Hepatitis C Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.8 Japan Hepatitis C Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.9 Southeast Asia Hepatitis C Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.10 India Hepatitis C Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

4 Global Hepatitis C Treatment Supply (Production), Consumption, Export, Import by Region (2013-2018)
4.1 Global Hepatitis C Treatment Consumption by Region (2013-2018)
4.2 North America Hepatitis C Treatment Production, Consumption, Export, Import (2013-2018)
4.3 Europe Hepatitis C Treatment Production, Consumption, Export, Import (2013-2018)
4.4 China Hepatitis C Treatment Production, Consumption, Export, Import (2013-2018)
4.5 Japan Hepatitis C Treatment Production, Consumption, Export, Import (2013-2018)
4.6 Southeast Asia Hepatitis C Treatment Production, Consumption, Export, Import (2013-2018)
4.7 India Hepatitis C Treatment Production, Consumption, Export, Import (2013-2018)

5 Global Hepatitis C Treatment Production, Revenue (Value), Price Trend by Type
5.1 Global Hepatitis C Treatment Production and Market Share by Type (2013-2018)
5.2 Global Hepatitis C Treatment Revenue and Market Share by Type (2013-2018)
5.3 Global Hepatitis C Treatment Price by Type (2013-2018)
5.4 Global Hepatitis C Treatment Production Growth by Type (2013-2018)

6 Global Hepatitis C Treatment Market Analysis by Application
6.1 Global Hepatitis C Treatment Consumption and Market Share by Application (2013-2018)
6.2 Global Hepatitis C Treatment Consumption Growth Rate by Application (2013-2018)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

7 Global Hepatitis C Treatment Manufacturers Profiles/Analysis
7.1 AbbieVie Inc.
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Hepatitis C Treatment Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 AbbieVie Inc. Hepatitis C Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.1.4 Main Business/Business Overview
7.2 Bristol-Myers Squibb Company
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Hepatitis C Treatment Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Bristol-Myers Squibb Company Hepatitis C Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.2.4 Main Business/Business Overview
7.3 F. Hoffmann-La Roche AG
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Hepatitis C Treatment Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 F. Hoffmann-La Roche AG Hepatitis C Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.3.4 Main Business/Business Overview
7.4 Gilead Sciences Inc.
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Hepatitis C Treatment Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Gilead Sciences Inc. Hepatitis C Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.4.4 Main Business/Business Overview
7.5 GlaxoSmith Kline Plc.
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Hepatitis C Treatment Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 GlaxoSmith Kline Plc. Hepatitis C Treatment Capacity, Production, Revenue, Price and Gross Margin (2015-2018)
7.5.4 Main Business/Business Overview
7.6 Janssen Pharmaceuticals Inc.
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Hepatitis C Treatment Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Janssen Pharmaceuticals Inc. Hepatitis C Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.6.4 Main Business/Business Overview
7.7 Merck & Co. Inc.
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Hepatitis C Treatment Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Merck & Co. Inc. Hepatitis C Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.7.4 Main Business/Business Overview
7.8 Schering AG
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Hepatitis C Treatment Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Schering AG Hepatitis C Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.8.4 Main Business/Business Overview
7.9 Vertex Pharmaceuticals
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Hepatitis C Treatment Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Vertex Pharmaceuticals Hepatitis C Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.9.4 Main Business/Business Overview

8 Hepatitis C Treatment Manufacturing Cost Analysis
8.1 Hepatitis C Treatment Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Hepatitis C Treatment

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Hepatitis C Treatment Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Hepatitis C Treatment Major Manufacturers in 2017
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 Global Hepatitis C Treatment Market Forecast (2018-2025)
12.1 Global Hepatitis C Treatment Capacity, Production, Revenue Forecast (2018-2025)
12.1.1 Global Hepatitis C Treatment Capacity, Production and Growth Rate Forecast (2018-2025)
12.1.2 Global Hepatitis C Treatment Revenue and Growth Rate Forecast (2018-2025)
12.1.3 Global Hepatitis C Treatment Price and Trend Forecast (2018-2025)
12.2 Global Hepatitis C Treatment Production, Consumption , Import and Export Forecast by Region (2018-2025)
12.2.1 North America Hepatitis C Treatment Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.2 Europe Hepatitis C Treatment Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.3 China Hepatitis C Treatment Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.4 Japan Hepatitis C Treatment Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.5 Southeast Asia Hepatitis C Treatment Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.6 India Hepatitis C Treatment Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.3 Global Hepatitis C Treatment Production, Revenue and Price Forecast by Type (2018-2025)
12.4 Global Hepatitis C Treatment Consumption Forecast by Application (2018-2025)

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer